Peceleganan spray improves healing of infected burn wounds in phase IIIb trial
The topical antimicrobial peptide PL-5 also improved bacterial clearance with no systemic absorption detected, according to the trial report.
PR
By Priya Raman · Science Reporter
Oct 17 17:56 ETSource: bioengineer.org
The wire
- 01A phase IIIb trial found peceleganan (PL-5) spray significantly improved complete healing and bacterial clearance in mild infected burn wounds.
- 02The result adds late-stage human data for a topical antimicrobial peptide used as the therapy itself, a category clinicians mostly see only in early research.
- 03Reported details are limited to the summary; enrollment, comparator and effect sizes are not given here, and infection severity was restricted to mild wounds.
From the source
Read at bioengineer.orgAntimicrobial Peptide Spray PL-5 Speeds Healing of Infected Burn Wounds in Late-Stage Trial
A phase IIIb trial found that the antimicrobial peptide spray peceleganan (PL-5) significantly improved complete healing and bacterial clearance in mild infected burn wounds without systemic absorption.
